Fanconi anemia : a disorder defective in the DNA damage response
Fanconi anemia : a disorder defective in the DNA damage response
复制标题
范可尼贫血:一种 DNA 损伤反应缺陷的疾病
DOI:
10.1007/s12185-011-0832-9
复制
发表时间:
2011
期刊:
影响因子:
2.1
通讯作者:
Takata M
中科院分区:
文献类型:
--
作者:
Kitao H;Takata M
Every cell in our body other than red blood cells has a genome, the stability of which is crucial for life. The DNA is precisely replicated during cell proliferation, and is stably maintained, even after terminal differentiation, as a repository of information that orchestrates the cell’s metabolism. Unfortunately, our world is full of potential threats to genomic stability. DNA may degrade spontaneously, errors may occur during its replication, or metabolic byproducts, such as oxygen radicals or aldehydes, may chemically modify its nucleotide bases (ie DNA adducts). Ionizing radiation, ultraviolet light, and chemotherapeutic drugs are all well-known exogenous sources of DNA damage [1, 2].To ensure cellular fitness, organisms have developed an elaborate molecular network to detect and repair DNA damage [3]. If deleterious effects of DNA damage exceed the cell’s repair capacity, it accumulates in the genome, leading to activation of cell cycle checkpoints (buying time for repair), cell death (apoptosis or necrosis), or, in the failure of checkpoints or cell death, conversion of DNA damage to mutations. This may result in poor cell proliferation, emergence of malignancy, impaired stem cell maintenance, or early-onset aging [1, 2]. Since all cellular activity in a way relies on the genome, the mechanisms that govern genomic stability are fundamentally important in biomedical research in general. Blood cells are no exception.